已收盘 02-27 16:00:00 美东时间
0.000
NaN.00%
Outlook Therapeutics' stock fell to a new low due to FDA rejection of its Lytenava filing for wet AMD. Efficacy evidence remains key issue.
01-02 21:18
Shares of Baidu Inc (NASDAQ:BIDU) rose sharply in pre-market trading after the ...
01-02 17:30
U.S. stock futures up, Apple reduces Vision Pro production, TSMC gets U.S. export license, VS Media announces share combination.
01-02 15:19